Pathologic correlates of survival in 378 lymph node-negative infiltrating ductal breast carcinomas. Mitotic count is the best single predictor
- PMID: 1651805
- DOI: 10.1002/1097-0142(19910915)68:6<1309::aid-cncr2820680621>3.0.co;2-i
Pathologic correlates of survival in 378 lymph node-negative infiltrating ductal breast carcinomas. Mitotic count is the best single predictor
Abstract
Pathologic features of 378 breast carcinomas without axillary lymph node metastases were correlated with long-term prognosis. Mitotic count, the feature best predicting prognosis, was most useful at lower mitotic count levels than usually studied. Cases with less than 4.5 mitotic figures per ten high-power fields had a 20-year tumor-related survival of 73% versus 48% for those with higher mitotic counts. Low and high mitotic count groups had significantly different prognoses for T1c, T2, and T3 tumors. Multivariate analysis showed that the best combination of features predicting tumor-related death were high mitotic count (relative risk, x 2.8), large tumor size (relative risk, x 1.7), lymphatic invasion (relative risk, x 1.7), and skin or subjacent muscle or chest wall invasion (relative risk, x 2.5). Nuclear grade, Bloom-Richardson grade, modified Scarff-Bloom-Richardson grade, Fisher's grade, and necrosis correlated well with survival but had no significant additional predictive value when adjusted for the mitotic count.
Similar articles
-
Pathologic correlates of prognosis in lymph node-positive breast carcinomas.Cancer. 1993 Mar 1;71(5):1780-90. doi: 10.1002/1097-0142(19930301)71:5<1780::aid-cncr2820710512>3.0.co;2-2. Cancer. 1993. PMID: 8383579
-
Prognostic value of histologic grade nuclear components of Scarff-Bloom-Richardson (SBR). An improved score modification based on a multivariate analysis of 1262 invasive ductal breast carcinomas.Cancer. 1989 Nov 1;64(9):1914-21. doi: 10.1002/1097-0142(19891101)64:9<1914::aid-cncr2820640926>3.0.co;2-g. Cancer. 1989. PMID: 2551477
-
Prognostic value of DNA cytometry in 281 premenopausal patients with lymph node negative breast carcinoma randomized in a control trial: multivariate analysis with Ki-67 index, mitotic count, and microvessel density.Cancer. 2000 Oct 15;89(8):1748-57. doi: 10.1002/1097-0142(20001015)89:8<1748::aid-cncr15>3.0.co;2-e. Cancer. 2000. PMID: 11042570 Clinical Trial.
-
A proposal for a new histological classification scheme for predicting short-term tumor recurrence and death in patients with invasive ductal carcinoma of the breast.Jpn J Cancer Res. 1998 Dec;89(12):1358-73. doi: 10.1111/j.1349-7006.1998.tb00534.x. Jpn J Cancer Res. 1998. PMID: 10081498 Free PMC article.
-
Staging in the therapy of cancer of the breast.Am J Clin Pathol. 1975 Dec;64(6):756-63. doi: 10.1093/ajcp/64.6.756. Am J Clin Pathol. 1975. PMID: 173178 Review.
Cited by
-
Prognostic factors in node-negative breast cancer: a review of studies with sample size more than 200 and follow-up more than 5 years.Ann Surg. 2002 Jan;235(1):10-26. doi: 10.1097/00000658-200201000-00003. Ann Surg. 2002. PMID: 11753038 Free PMC article. Review.
-
Clinicopathologic study associated with long-term survival in Japanese patients with node-negative breast cancer.Br J Cancer. 2000 Jan;82(2):404-11. doi: 10.1054/bjoc.1999.0934. Br J Cancer. 2000. PMID: 10646896 Free PMC article.
-
Morphometrical malignancy grading is a valuable prognostic factor in invasive ductal breast cancer.Br J Cancer. 2002 Nov 18;87(11):1275-80. doi: 10.1038/sj.bjc.6600617. Br J Cancer. 2002. PMID: 12439717 Free PMC article.
-
Tumour size and vascular invasion predict distant metastasis in stage I breast cancer. Grade distinguishes early and late metastasis.J Clin Pathol. 2005 Feb;58(2):196-201. doi: 10.1136/jcp.2004.018515. J Clin Pathol. 2005. PMID: 15677542 Free PMC article.
-
MIB-1 labelling index is an independent prognostic marker in primary breast cancer.Br J Cancer. 1998 Aug;78(4):460-5. doi: 10.1038/bjc.1998.515. Br J Cancer. 1998. PMID: 9716027 Free PMC article.
MeSH terms
LinkOut - more resources
Other Literature Sources
Medical